Can a Child Take Trazodone? Uses, Safety & Side Effects

Children can and do take trazodone, but it is prescribed entirely off-label because the drug has never been approved by the FDA for any use in pediatric patients. Trazodone was developed and approved as an antidepressant for adults, yet in pediatric practice it is overwhelmingly used for a different purpose: helping children fall and stay asleep. The gap between how widely it is prescribed to kids and how little clinical trial evidence exists to support that use is striking, and it is something every parent should understand before filling a prescription.

Why Doctors Prescribe Trazodone to Children

The most common reason a child ends up on trazodone is insomnia, often tied to another condition. Children with attention deficit hyperactivity disorder (ADHD) are especially likely to receive it, in part because stimulant medications used for ADHD can make it harder to fall asleep. A study of Medicaid-insured children in Oregon found that out of more than 32,000 children with ADHD, roughly 8.4 percent had filled at least one trazodone prescription. Children with ADHD who were prescribed trazodone were about three times more likely to carry a sleep-related diagnosis compared to children of the same age and sex who were not on the drug.¹

Sleep problems in children are not limited to ADHD, of course. Kids with autism spectrum disorder, anxiety disorders, depression, and post-traumatic stress frequently struggle with sleep, and prescribers sometimes reach for trazodone in those contexts too. The pattern is consistent across studies: trazodone is prescribed to children without the backing of national treatment guidelines or robust clinical evidence for efficacy in that age group.² That does not necessarily mean the drug is harmful or useless in children, but it does mean prescribers are relying on clinical judgment and extrapolation from adult data rather than well-controlled pediatric trials.

How Trazodone Works at Different Doses

Trazodone’s effects shift depending on how much you take, and that dose-dependent behavior is key to understanding why it is used for sleep rather than depression in children. At low doses, trazodone strongly blocks certain receptors in the brain responsible for promoting wakefulness and arousal. Pharmacokinetic modeling suggests that a dose around 50 mg in an adult is enough to occupy the receptors that produce a sedative, sleep-promoting effect.³ Getting an antidepressant effect requires substantially higher doses, typically 150 to 300 mg or more in adults, because the serotonin-related targets that lift mood only become meaningfully occupied at those higher levels.

For children, the doses prescribed for sleep are generally much lower than what adults take, and they are usually calculated by body weight. A modeling study designed to predict appropriate pediatric dosing estimated that for children aged two to six, a dose of about 0.35 mg per kilogram of body weight would approximate the exposure an adult gets from a 30 mg dose. For children over six through twelve, the equivalent figure was about 0.4 mg/kg, and for adolescents twelve to seventeen, roughly the same. Higher weight-based doses were modeled for exposures matching adult doses of 75 mg and 150 mg, but these are intended for research guidance, not bedside prescribing.⁴ The important takeaway is that the study authors noted a fundamental problem: actual pharmacokinetic data on trazodone in children are lacking, so these dose predictions are based on computer simulations rather than measurements from real pediatric patients.

The Evidence Problem

This is where the story gets uncomfortable. Trazodone is one of the most commonly prescribed medications for sleep in children, yet the clinical evidence supporting its use in this population is remarkably thin. There are no large, randomized, placebo-controlled trials establishing that trazodone is effective for pediatric insomnia. The studies that do exist tend to be small, observational, or focused on specific subpopulations like children with neurodevelopmental conditions.

When it comes to depression, the picture is even less encouraging. One study of adolescents with depression who were being treated with serotonin reuptake inhibitors (SRIs) found that adding trazodone was associated with a worse outcome, not a better one. Adolescents exposed to trazodone were significantly more likely to be classified as non-responders to their depression treatment.⁵ That is a single observational study, not a definitive verdict, but it reinforces the point that trazodone’s role in pediatric mental health beyond sleep remains unproven. Clinicians who prescribe it for sleep generally are not expecting it to treat the child’s underlying psychiatric condition; they are targeting the insomnia specifically.

Side Effects Parents Should Know About

In adults, trazodone’s most common side effect is next-day drowsiness. Children experience a similar profile, but there are some side effects that deserve specific attention in the pediatric context.

A sixteen-year analysis of poison center data on unintentional trazodone overdoses in children six years old and younger found that most accidental exposures resulted in no clinical effects at all: about 62 percent of the 84 children studied were completely unaffected. Roughly 35 percent had minor effects like vomiting, dizziness, or headache. Three children, about 4 percent, experienced moderate effects including unsteady walking, slurred speech, and in one case, priapism.⁶ All of the children recovered fully without lasting harm.

Those findings reflect accidental ingestions, not therapeutic dosing. At prescribed doses, the side effects children may experience include:

Daytime sleepiness: The most frequently reported issue, particularly if the dose is too high or given too early in the evening.
Dizziness or lightheadedness: Trazodone can cause a drop in blood pressure upon standing, which may make a child feel woozy when getting out of bed.
Nausea or stomach discomfort: Usually mild and often improves after the first few days.
Headache: Reported in some children, though it can be hard to distinguish from symptoms of the underlying condition.

Priapism, a Rare but Serious Risk

Priapism is a prolonged, painful erection unrelated to sexual arousal, and it is a known risk with trazodone at any age. In adults, the estimated incidence is low, but the consequence can be severe: untreated priapism can cause permanent damage. In the poison center study mentioned above, one case of priapism occurred in a two-year-old boy after an accidental dose of 6.9 mg/kg, which is well above any therapeutic dose.⁶ At standard prescribed doses this is exceedingly rare, but parents of boys taking trazodone should be aware of the possibility and know that it requires immediate medical attention if it occurs. The child does not need to be old enough to articulate the problem; caregivers should watch for signs of discomfort or swelling.

Heart Rhythm Concerns

Trazodone, like many psychiatric medications, has the potential to affect the electrical activity of the heart. The specific concern is QT prolongation, a change in the heart’s electrical cycle that in rare cases can trigger dangerous irregular heartbeats. This risk exists in adults and children alike, but it takes on added significance in pediatrics because children are frequently on multiple psychiatric medications simultaneously, and many of those drugs also carry QT-prolonging potential.

A study of contraindicated medication combinations in a pediatric population found that the most common risky drug pairs were those that increased the potential for prolonged QT interval and serotonin syndrome. Among the children studied, 378 were found to be on contraindicated combinations raising QT risk, and 250 were on combinations raising serotonin syndrome risk.⁷ Trazodone was among the medications flagged in these combinations. The practical implication: if your child is already on another medication, especially an antidepressant, antipsychotic, or stimulant, make sure the prescriber knows about every drug your child takes, including over-the-counter products.

Drug Interactions and Serotonin Syndrome

Serotonin syndrome is a potentially life-threatening condition that occurs when too much serotonin builds up in the brain. Because trazodone increases serotonin activity, combining it with other serotonin-boosting medications raises the risk. This is not a theoretical concern restricted to unusual drug cocktails. Many of the most commonly prescribed pediatric psychiatric medications, including SSRIs like fluoxetine and sertraline, affect serotonin. When a child is taking an SSRI for depression or anxiety and trazodone is added for sleep, the combination nudges serotonin levels higher than either drug would alone.

Signs of serotonin syndrome include agitation, rapid heartbeat, high blood pressure, dilated pupils, muscle twitching, diarrhea, and in severe cases, high fever and seizures. Most cases are mild and resolve quickly when the offending drug is stopped, but severe cases require emergency treatment. The study of contraindicated medication pairs in pediatric patients found that serotonin syndrome risk was one of the two most frequently encountered dangers, alongside QT prolongation.⁷

Another interaction worth knowing about involves atomoxetine, a non-stimulant medication used for ADHD. The same pharmacokinetic modeling study that predicted trazodone doses for children also examined what happens when trazodone and atomoxetine are taken together. Both drugs are processed by the same liver enzyme, and taking them together can slow down the breakdown of trazodone, effectively increasing its concentration in the body. The study predicted that the interaction could raise trazodone levels meaningfully, though the clinical significance depends on the doses involved.⁴

What Clinical Guidelines Actually Recommend for Pediatric Sleep Problems

If the evidence for trazodone in children is so thin, what are parents and clinicians supposed to do instead? Sleep medicine guidelines consistently recommend starting with non-drug approaches. The American Academy of Sleep Medicine’s guidelines for insomnia management prioritize behavioral and psychotherapeutic strategies, and there is growing evidence that these approaches work well in children and adolescents.⁸

In practice, behavioral approaches for pediatric insomnia include consistent bedtime routines, limiting screen exposure before bed, keeping the bedroom cool and dark, and addressing anxiety or worry through cognitive-behavioral techniques specifically adapted for insomnia. For younger children, structured bedtime fading (gradually shifting bedtime to match when the child naturally falls asleep, then slowly moving it earlier) has shown results in clinical settings.

Medication enters the picture when behavioral strategies have been tried and have not been enough, or when the child’s sleep disruption is so severe that it is causing significant daytime impairment. Even then, no sleep medication is FDA-approved for insomnia in children. Trazodone, melatonin, clonidine, and antihistamines like hydroxyzine are all used off-label. Of these, melatonin has the largest body of pediatric evidence, particularly for children with neurodevelopmental conditions, though it too has limitations. A survey of Canadian child and adolescent psychiatrists found that prescribing patterns for pediatric sleep problems varied widely, reflecting the lack of clear guideline-endorsed pharmacological options.⁸

Children With ADHD and the Stimulant-Insomnia Cycle

The overlap between ADHD treatment and trazodone use deserves its own consideration because it is so common. Stimulant medications like methylphenidate and amphetamine salts are the first-line treatment for ADHD and are effective for the majority of children who take them. But stimulants are, by definition, activating. Delayed sleep onset is one of the most frequently reported side effects of stimulant use in children. Parents often describe a child who is calmer and more focused during the day but who lies awake for hours at bedtime.

This creates a prescribing cycle: the child needs the stimulant for daytime functioning, but the stimulant disrupts sleep, so a second medication is added at night. Trazodone fills that role frequently. The Oregon Medicaid study found that children with ADHD were being prescribed trazodone for conditions with no national guidelines or clinical evidence of efficacy.¹ That does not mean every one of those prescriptions was inappropriate. It means the decision is being made without the safety net of established guidelines, placing more weight on the individual clinician’s experience and judgment.

Before adding trazodone, it is worth asking whether the stimulant dose or timing can be adjusted. Shorter-acting stimulant formulations taken earlier in the day may cause less sleep disruption than long-acting versions that persist into the evening. Some children do better switching to a non-stimulant ADHD medication altogether. These adjustments do not always solve the problem, but they are worth exploring before layering on a second medication.

What Happens if a Child Accidentally Takes Trazodone

Accidental ingestions are a real concern because trazodone tablets look like any other pill and are often stored in households where a child could reach them. The poison center data spanning sixteen years offers some reassurance: even in accidental overdose scenarios, the vast majority of young children who swallowed trazodone had no symptoms or only mild ones like temporary drowsiness and vomiting.⁶ Moderate effects like unsteady gait and slurred speech only showed up at doses above 6.9 mg/kg, well beyond what a child would typically encounter from swallowing a single adult tablet. Still, any suspected accidental ingestion warrants a call to Poison Control (1-800-222-1222 in the United States) or a trip to the emergency room, especially if the child is showing any signs of unusual sleepiness or behavior changes.

Stopping Trazodone in Children

Trazodone is not considered physically addictive in the way that benzodiazepines or opioids are, but stopping it abruptly after regular use can produce withdrawal-like symptoms. Adults who discontinue trazodone suddenly sometimes report irritability, anxiety, disrupted sleep (a rebound of the very symptom it was treating), and general unease. There is no reason to think children would be immune to these effects, though the research specifically documenting trazodone discontinuation in pediatric patients is sparse.

The standard recommendation is to taper gradually rather than stopping all at once, under the guidance of the prescribing clinician. If a child has been taking trazodone nightly for weeks or months, the dose is typically reduced in small steps over a period of one to two weeks. Parents should also be prepared for a few rough nights of sleep after discontinuation, since the underlying sleep difficulty may still be present once the medication is removed.

The FDA’s Black Box Warning

Because trazodone is classified as an antidepressant, it carries the FDA’s black box warning about increased risk of suicidal thinking and behavior in children, adolescents, and young adults. This warning applies to all antidepressants, not just trazodone, and it was added based on pooled analyses of clinical trials showing a small increase in suicidal ideation in younger patients starting these drugs. The warning does not mean trazodone causes suicide; it means that during the early weeks of treatment, some young people experience worsening mood or new thoughts of self-harm.

When trazodone is prescribed at low doses for sleep, the clinical relevance of this warning is debated. The doses used for insomnia are typically well below the antidepressant range, and the warning was generated from trials studying antidepressant-level dosing. Still, the label is there, and prescribers are expected to counsel families about monitoring mood changes during the first several weeks of treatment. Any new or worsening thoughts of self-harm, increased agitation, or marked behavioral changes should be reported to the prescriber immediately.

When Trazodone Might Be a Reasonable Choice

Despite the evidence gaps, there are situations where trazodone makes clinical sense for a child. A child who has tried consistent sleep hygiene, behavioral interventions, and melatonin without adequate improvement, and whose sleep deprivation is seriously affecting their daytime functioning, school performance, or family life, may benefit from a trial of trazodone at a low dose. The drug has a relatively favorable safety profile at low doses compared to alternatives like benzodiazepines, which carry a real risk of dependence and next-day cognitive impairment. It is also inexpensive and widely available as a generic.

The decision is best made collaboratively between the parent and a clinician who is familiar with the child’s full medical and psychiatric picture. Questions worth asking include whether the child is on other medications that could interact with trazodone, whether the underlying cause of the sleep difficulty has been adequately addressed, what the planned duration of treatment is, and what the exit strategy looks like. Open-ended prescriptions renewed automatically for months or years without reassessment represent the less careful end of the prescribing spectrum, and they are more common than they should be.